Article History
Received: 14 July 2017
Accepted: 19 September 2017
First Online: 12 February 2018
Competing Interests
: One of the authors (P.W.) is an inventor of the PCT applications WO/2010/120726: “Treatment of inflammatory diseases by the inhibition of cold shock proteins” and US 61/881,798: “Peptides inhibiting cold-inducible RNA binding protein activity”. These patent applications cover the fundamental concept of inhibiting CIRP for the treatment of inflammatory diseases. The other authors have no conflict of interest.